| Difficult but feasible goal (3) (Line) | |
|---|---|
| X | Y |
| 2005 | 23.17 |
| 2006 | 22.91 |
| 2007 | 22.95 |
| 2008 | 23.39 |
| 2009 | 23.87 |
| 2010 | 24.37 |
| 2011 | 24.53 |
| 2012 | 24.79 |
| 2013 | 25.22 |
| 2014 | 25.59 |
| 2015 | 25.98 |
| 2016 | 25.76 |
| 2017 | 25.58 |
| 2018 | 25.66 |
| 2019 | 25.74 |
| 2020 | 26.24 |
| Healthy People 2010 goal met (3)(1) (Line) | |
| X | Y |
| 2005 | 25.81 |
| 2006 | 27.37 |
| 2007 | 28.52 |
| 2008 | 29.81 |
| 2009 | 30.96 |
| 2010 | 32.16 |
| 2011 | 32.9 |
| 2012 | 33.57 |
| 2013 | 34.22 |
| 2014 | 34.88 |
| 2015 | 35.46 |
| 2016 | 35.21 |
| 2017 | 34.92 |
| 2018 | 34.98 |
| 2019 | 34.94 |
| 2020 | 35.32 |
| NHIS data (4) (Scatter) | |
| X | Scale label |
| 2000 | 25.33% |
| 2003 | 25% |
| 2005 | 23% |
| NHIS data (2) (4) (Scatter) | |
| X | Scale label |
| 1987 | 4.59% |
| 1992 | 11.4% |
| 1998 | 12.4% |
| Home FOBT in the past 2 years trend (1970-2004) (Line) | |
| X | Y |
| 1979 | 1.31 |
| 1980 | 2.7 |
| 1981 | 3.44 |
| 1982 | 4.16 |
| 1983 | 4.88 |
| 1984 | 5.67 |
| 1985 | 6.64 |
| 1986 | 7.6 |
| 1987 | 8.57 |
| 1988 | 10.05 |
| 1989 | 11.63 |
| 1990 | 13.09 |
| 1991 | 14.42 |
| 1992 | 15.86 |
| 1993 | 15.67 |
| 1994 | 15.53 |
| 1995 | 15.89 |
| 1996 | 16.35 |
| 1997 | 16.85 |
| 1998 | 17.35 |
| 1999 | 19.95 |
| 2000 | 22.44 |
| 2001 | 22.48 |
| 2002 | 22.7 |
| 2003 | 23.02 |
| 2004 | 23.35 |
| 2005 | 22.99 |
| Projected home FOBT in the past 2 years trend (2005-2020) (Line) | |
| X | Y |
| 2005 | 22.99 |
| 2006 | 22.08 |
| 2007 | 21.29 |
| 2008 | 21.01 |
| 2009 | 20.8 |
| 2010 | 20.55 |
| 2011 | 20.02 |
| 2012 | 19.59 |
| 2013 | 19.25 |
| 2014 | 18.91 |
| 2015 | 18.63 |
| 2016 | 18.02 |
| 2017 | 17.53 |
| 2018 | 17.1 |
| 2019 | 16.74 |
| 2020 | 16.75 |
| Healthy People 2010 U.S. Target (1) (Scatter) | |
| X | Scale label |
| 2010 | 33% |
Footnotes:
[1] The official Healthy People 2010 objective is to increase the proportion of adults aged 50+ receiving a fecal occult blood test (FOBT) in the past two years to 50%. The location of the test (i.e., home or office) was not specified. Since the sensitivity for detecting advanced neoplasia is much higher for home-based FOBTs (23.9%) than for office-based FOBTs (4.9%) (Collins et al., Ann Intern Med 2005), we restated the Healthy People 2010 goal as to increase the proportion of adults aged 50+ receiving a home-based FOBT in the past two years to 50%.
[2] Age adjusted to the 2000 standard population using age groups 50-64y and 65+y.
[3] Trend assumed to be flat after the Healthy People 2010 objective is met.
[4] The NHIS questions regarding history of FOBT vary by year. In the 2000 and 2003, respondents were asked when they had their last home-based FOBT (red diamonds). Prior to 2000, respondents were asked when they had their last FOBT and whether their last FOBT was a home- or an office-based test. We used two approaches to estimate the proportion receiving a home-based FOBT in the past two years prior to the year 2000. In one approach we assumed that if the last test was an office-based FOBT, then the person would not have had a home-based test in the previous two years (red stars). In the second approach we estimated the proportion having a home-based FOBT prior to 2000 assuming that the proportion of total FOBTs that are home-based is the same as the proportion observed in 2000 (red crosses).